Pamela Bhatti Leads Georgia Tech's School of Electrical and Computer Engineering in Innovation and Entrepreneurship
Pamela Bhatti, PhD, MSc, has been appointed as the new Associate Chair for Innovation and Entrepreneurship in the Georgia Tech School of Electrical and Computer Engineering (ECE).
Dr. Bhatti is a former KL2 scholar and a graduate of the CTSA-supported Emory Master of Science in Clinical Research (MSCR). She now serves as the Georgia Tech co-director for the Georgia Clinical and Translational Science Alliance (Georgia CTSA) KL2 and TL1 clinical and translational research training programs. She also serves on the Georgia CTSA Research Education Executive Committee.
Dr. Bhatti is also a major contributor to Georgia CTSA’s Innovation Catalyst program. She is an entrepreneurship educator and coach with the I-Corps@NCATS program, as well as for the Georgia Tech CREATE-X and InVenture Prize programs.
The Emory Master of Science in Clinical Research (MSCR) degree program, in the Laney Graduate School at Emory University, is supported by Georgia CTSA and provides innovative didactic and mentored research training to those interested in pursuing a career in clinical and/or translational research. The MSCR degree is designed for predoctoral (medical students, PhD students or PharmD students), postdoctoral trainees (resident and fellow physicians or PhD postdocs), and junior faculty (physicians, PhD-level scientists or PharmDs) from Emory University (Emory), Morehouse School of Medicine (MSM), Georgia Institute of Technology (Georgia Tech) and the University of Georgia (UGA).
The Georgia CTSA Research Education program focuses on long-term didactic and mentored clinical and translational research training through a variety of initiatives. The program provides clinical and translational research training opportunities including the Master of Science in Clinical Research (MSCR) degree, a Certificate Program in Translational Research (CPTR), as well as a the KL2 and TL1 programs.
Georgia CTSA provides resources for start-up research projects through the Innovation Catalyst program. Innovation Catalyst offers funding for start-up research projects, better access to analytical tools, and education and training to clinical and translational investigators. Georgia CTSA provides the infrastructure and programmatic foundation to rapidly identify and invest in promising technologies and enhance collaborative opportunities among translational investigators and industry partners. A goal of Georgia CTSA is to catalyze development, validation, and commercialization of translational technologies.
The Georgia CTSA is a statewide partnership between Emory, Morehouse School of Medicine, Georgia Tech, and UGA and is one of over 60 in a national consortium striving to improve the way biomedical research is conducted across the country. The consortium, funded through the National Center for Advancing Translational Sciences (NCATS) and the National Institutes of Health’s Clinical and Translational Science Awards, shares a common vision to translate laboratory discoveries into treatments for patients, engage communities in clinical research efforts, and train the next generation of clinical investigators.